MIRVETUXIMAB SORAVTANSINE

MIRVETUXIMAB SORAVTANSINE was reported 1814 times

MIRVETUXIMAB SORAVTANSINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIGH GRADE SEROUS OVARIAN CARCINOMA 10 0.5263
1 SHALLOW ANTERIOR CHAMBER 1 0.1429
2 MALIGNANT URINARY TRACT OBSTRUCTION 1 0.1250
3 MOISTURE-ASSOCIATED SKIN DAMAGE 1 0.1250
4 PARANEOPLASTIC THROMBOSIS 1 0.1000
5 DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS 1 0.0833
6 OVARIAN EPITHELIAL CANCER 13 0.0681
7 PERITONEAL NECROSIS 1 0.0625
8 EYE ABRASION 3 0.0566
9 CANCER SCREENING ABNORMAL 1 0.0526
10 CORNEAL EPITHELIAL MICROCYSTS 8 0.0479
11 METASTASES TO VAGINA 1 0.0455
12 METASTASES TO MOUTH 1 0.0435
13 PARANEOPLASTIC PLEURAL EFFUSION 1 0.0417
14 OCULAR TOXICITY 46 0.0417
15 KERATOPATHY 60 0.0379
16 PERITONEAL THICKENING 1 0.0357
17 CARBOHYDRATE ANTIGEN 125 1 0.0333
18 CORNEAL CYST 3 0.0309
19 METASTASES TO URINARY TRACT 1 0.0303
20 RECTOSIGMOID CANCER METASTATIC 1 0.0270
21 CORNEAL TOXICITY 3 0.0270
22 INTRACRANIAL CALCIFICATION 1 0.0270
23 CORNEAL EPITHELIOPATHY 1 0.0263
24 BURKHOLDERIA INFECTION 2 0.0241
25 MUSCLE NEOPLASM 1 0.0222
26 OVARIAN EPITHELIAL CANCER RECURRENT 1 0.0185
27 NEUROTROPHIC KERATOPATHY 1 0.0185
28 BOWEL OBSTRUCTION SURGERY 1 0.0182
29 KERATITIS 55 0.0181
30 CORNEAL PIGMENTATION 1 0.0175
31 INCISION SITE RASH 1 0.0167
32 CORNEAL DEPOSITS 12 0.0161
33 CSF LYMPHOCYTE COUNT INCREASED 1 0.0161
34 SECONDARY CEREBELLAR DEGENERATION 1 0.0161
35 PERITONEAL CARCINOMA METASTATIC 1 0.0159
36 METASTASES TO DIAPHRAGM 1 0.0147
37 PUNCTATE KERATITIS 13 0.0142
38 OVARIAN CANCER METASTATIC 12 0.0141
39 FALLOPIAN TUBE CANCER 2 0.0139
40 OCULAR CYST 1 0.0135
41 CATHETER SITE DISCOMFORT 1 0.0125
42 CORNEAL IRRITATION 1 0.0125
43 PERITONEAL LESION 1 0.0123
44 LIMBAL STEM CELL DEFICIENCY 1 0.0122
45 MALIGNANT GASTROINTESTINAL OBSTRUCTION 1 0.0119
46 MACULAR THICKENING 1 0.0119
47 PSEUDOPHAKIA 1 0.0115
48 TOXIC NEUROPATHY 4 0.0102
49 CATARACT SUBCAPSULAR 6 0.0098
50 BLOOD BILIRUBIN ABNORMAL 12 0.0094
51 PERITONEAL NEOPLASM 1 0.0093
52 DEVICE AUDIO ISSUE 1 0.0093
53 TUMOUR INFLAMMATION 1 0.0089
54 OVARIAN CANCER STAGE III 3 0.0086
55 CORNEAL EPITHELIUM DEFECT 5 0.0086
56 CARBOHYDRATE ANTIGEN 125 INCREASED 29 0.0085
57 INCISION SITE INFLAMMATION 1 0.0085
58 PERIPHERAL VEIN OCCLUSION 1 0.0084
59 NECROTIC LYMPHADENOPATHY 1 0.0083
60 ASPARTATE AMINOTRANSFERASE ABNORMAL 12 0.0079
61 LYMPHATIC SYSTEM NEOPLASM 1 0.0077
62 INJURY CORNEAL 4 0.0077
63 QUADRANTANOPIA 1 0.0076
64 CORNEAL DEFECT 1 0.0076
65 CATARACT CORTICAL 1 0.0067
66 CORNEAL LESION 2 0.0065
67 NASAL MUCOSAL DISCOLOURATION 1 0.0062
68 BLOOD CHLORIDE ABNORMAL 1 0.0062
69 ALANINE AMINOTRANSFERASE ABNORMAL 12 0.0057
70 PERICARDIAL EFFUSION MALIGNANT 1 0.0056
71 SCAN ABNORMAL 2 0.0054
72 SICCA SYNDROME 1 0.0052
73 METASTASES TO PERITONEUM 13 0.0051
74 DOSE CALCULATION ERROR 3 0.0051
75 DUODENAL PERFORATION 5 0.0051
76 CATHETER SITE EXTRAVASATION 2 0.0050
77 ADMINISTRATION SITE EXTRAVASATION 5 0.0050
78 SALPINGO-OOPHORECTOMY BILATERAL 1 0.0050
79 NEUTROPHIL COUNT ABNORMAL 14 0.0049
80 HYPERINSULINAEMIC HYPOGLYCAEMIA 1 0.0045
81 SENSORY LEVEL ABNORMAL 1 0.0044
82 CATHETER SITE RASH 2 0.0044
83 CORNEAL OPACITY 6 0.0044
84 PLEURAL INFECTION 1 0.0043
85 HEPATIC MASS 8 0.0041
86 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 1 0.0041
87 KERATOMILEUSIS 1 0.0039
88 DISEASE SUSCEPTIBILITY 1 0.0036
89 OVARIAN CANCER 33 0.0036
90 EXCESSIVE SKIN 1 0.0035
91 INTERNATIONAL NORMALISED RATIO ABNORMAL 12 0.0035
92 PNEUMONITIS 95 0.0035
93 BLOOD CREATININE ABNORMAL 12 0.0035
94 MALIGNANT PERITONEAL NEOPLASM 2 0.0034
95 CORONARY ARTERY EMBOLISM 1 0.0034
96 VISUAL ACUITY REDUCED TRANSIENTLY 1 0.0032
97 CORNEAL DISORDER 7 0.0032
98 CORNEAL INFILTRATES 1 0.0032
99 CORNEAL PERFORATION 2 0.0032
100 METASTASES TO OVARY 1 0.0031
101 LYMPHADENOPATHY MEDIASTINAL 6 0.0031
102 VAGINAL CANCER 1 0.0031
103 HAEMATOLOGY TEST ABNORMAL 1 0.0031
104 LOSS OF PROPRIOCEPTION 1 0.0031
105 PARAKERATOSIS 1 0.0031
106 CATARACT NUCLEAR 2 0.0030
107 PSEUDOSTROKE 1 0.0029
108 DIAPHRAGMALGIA 1 0.0029
109 EYE SYMPTOM 1 0.0028
110 INVESTIGATION ABNORMAL 4 0.0028
111 SPLENIC LESION 1 0.0027
112 UROGENITAL HAEMORRHAGE 1 0.0027
113 PENILE ERYTHEMA 1 0.0027
114 CEREBELLAR STROKE 1 0.0026
115 METASTASES TO STOMACH 1 0.0026
116 BLUE TOE SYNDROME 1 0.0026
117 METASTATIC NEOPLASM 11 0.0025
118 DISEASE RISK FACTOR 1 0.0025
119 OVARIAN CANCER RECURRENT 4 0.0025
120 GENITAL ABSCESS 1 0.0025
121 LARYNGEAL PAIN 1 0.0025
122 BONE ABSCESS 1 0.0025
123 URETERAL DISORDER 1 0.0024
124 METASTASES TO SPLEEN 1 0.0024
125 OVARIAN CANCER STAGE IV 1 0.0024
126 CORNEAL DYSTROPHY 1 0.0024
127 ABDOMINAL CAVITY DRAINAGE 1 0.0024
128 GASTROINTESTINAL NEOPLASM 2 0.0023
129 HILAR LYMPHADENOPATHY 2 0.0023
130 GASTROINTESTINAL STENOSIS 1 0.0022
131 INCISION SITE ERYTHEMA 1 0.0022
132 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
133 HEART RATE ABNORMAL 12 0.0021
134 PERIPHERAL MOTOR NEUROPATHY 3 0.0021
135 PRODUCT PREPARATION ISSUE 14 0.0021
136 GASTROINTESTINAL STOMA OUTPUT INCREASED 1 0.0021
137 SOLAR LENTIGO 2 0.0021
138 OESOPHAGEAL ADENOCARCINOMA 1 0.0021
139 CELL MARKER INCREASED 1 0.0021
140 SKIN FIBROSIS 1 0.0021
141 EPIDERMAL NECROSIS 2 0.0021
142 HAEMOGLOBIN ABNORMAL 13 0.0020
143 BLADDER MASS 1 0.0020
144 EXPOSURE VIA PARTNER 1 0.0020
145 CORNEAL SCAR 1 0.0020
146 ASTIGMATISM 3 0.0020
147 ORBITAL OEDEMA 1 0.0020
148 GLARE 1 0.0019
149 EXTRAVASATION 8 0.0019
150 BLOOD ALBUMIN ABNORMAL 1 0.0019
151 PROCEDURAL SITE REACTION 1 0.0019
152 INFUSION SITE CELLULITIS 1 0.0019
153 CORNEAL EROSION 1 0.0019
154 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
155 PRESBYOPIA 1 0.0018
156 TUMOUR RUPTURE 1 0.0018
157 COLONIC FISTULA 1 0.0018
158 EYE ULCER 1 0.0017
159 SUTURE INSERTION 1 0.0017
160 XEROPHTHALMIA 1 0.0017
161 HYPOAESTHESIA EYE 1 0.0017
162 FULL BLOOD COUNT INCREASED 2 0.0017
163 SUSPECTED SUICIDE ATTEMPT 1 0.0017
164 MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0017
165 INTRA-ABDOMINAL FLUID COLLECTION 3 0.0017
166 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
167 PARACENTESIS 1 0.0016
168 INFLAMMATORY MARKER INCREASED 8 0.0016
169 INTESTINAL ANASTOMOSIS 1 0.0016
170 PERITONEAL DISORDER 1 0.0015
171 BILIARY OBSTRUCTION 2 0.0015
172 SHORT-BOWEL SYNDROME 1 0.0015
173 WRONG DEVICE USED 1 0.0015
174 LUNG OPACITY 4 0.0015
175 CATARACT 90 0.0015
176 INJECTION SITE EXFOLIATION 1 0.0015
177 CENTRAL SEROUS CHORIORETINOPATHY 1 0.0015
178 PLEURAL THICKENING 1 0.0015
179 ULCERATIVE KERATITIS 4 0.0015
180 SOFT TISSUE NECROSIS 1 0.0015
181 STOMA CREATION 1 0.0014
182 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
183 NEUTROPENIC SEPSIS 10 0.0014
184 ACCOMMODATION DISORDER 1 0.0014
185 OVARIAN MASS 1 0.0014
186 CORNEAL OEDEMA 3 0.0013
187 INTESTINAL PERFORATION 15 0.0013
188 BASOPHIL COUNT INCREASED 1 0.0013
189 MALIGNANT ASCITES 1 0.0013
190 PULMONARY ARTERY THROMBOSIS 1 0.0013
191 NEUROPATHY PERIPHERAL 120 0.0013
192 PELVIC MASS 1 0.0012
193 SMALL INTESTINAL OBSTRUCTION 15 0.0012
194 ENTEROCOLITIS 7 0.0012
195 DRY EYE 59 0.0012
196 VITAL FUNCTIONS ABNORMAL 1 0.0012
197 ABDOMINAL LYMPHADENOPATHY 1 0.0012
198 AXONAL NEUROPATHY 1 0.0011
199 ENTEROCUTANEOUS FISTULA 1 0.0011
200 ABDOMINAL NEOPLASM 1 0.0011
201 BONE CONTUSION 1 0.0011
202 SMALL INTESTINAL PERFORATION 2 0.0011
203 BLOOD UREA ABNORMAL 1 0.0011
204 WHITE BLOOD CELLS URINE POSITIVE 2 0.0011
205 INJECTION SITE ULCER 1 0.0011
206 HYPERMETROPIA 1 0.0011
207 WRONG SCHEDULE 1 0.0010
208 FOREIGN BODY IN EYE 1 0.0010
209 GASTROINTESTINAL TOXICITY 5 0.0010
210 COLON NEOPLASM 1 0.0010
211 TRAUMATIC LUNG INJURY 2 0.0010
212 BUTTERFLY RASH 1 0.0010
213 BREAST ABSCESS 1 0.0010
214 DISEASE PROGRESSION 108 0.0009
215 LARGE INTESTINAL OBSTRUCTION 2 0.0009
216 CATHETER SITE DISCHARGE 1 0.0009
217 PERIARTHRITIS 2 0.0009
218 VITH NERVE PARALYSIS 1 0.0009
219 PRODUCT PREPARATION ERROR 18 0.0009
220 VISION BLURRED 120 0.0009
221 INTERCEPTED MEDICATION ERROR 4 0.0009
222 PAROTITIS 1 0.0009
223 SMALL INTESTINAL RESECTION 1 0.0009
224 EYE DISORDER 28 0.0009
225 PHOTOPHOBIA 16 0.0008
226 MYOPIA 2 0.0008
227 TUMOUR MARKER INCREASED 4 0.0008
228 RENAL TUBULAR INJURY 1 0.0008
229 RETINAL TEAR 2 0.0008
230 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
231 PERIPHERAL SENSORIMOTOR NEUROPATHY 1 0.0008
232 DERMATOMYOSITIS 2 0.0008
233 BRONCHIAL SECRETION RETENTION 1 0.0008
234 INTERSTITIAL LUNG DISEASE 38 0.0008
235 PRODUCT TEMPERATURE EXCURSION ISSUE 4 0.0008
236 HERPES OPHTHALMIC 1 0.0008
237 BLEPHARITIS 3 0.0007
238 MACULAR HOLE 1 0.0007
239 CORNEAL ABRASION 1 0.0007
240 INFUSION SITE RASH 1 0.0007
241 FAT TISSUE INCREASED 1 0.0007
242 BLINDNESS 28 0.0007
243 BLINDNESS TRANSIENT 5 0.0007
244 INFERTILITY 1 0.0007
245 ADHESION 1 0.0007
246 PNEUMONIA PSEUDOMONAL 1 0.0007
247 INFUSION RELATED REACTION 43 0.0006
248 INFUSION SITE EXTRAVASATION 4 0.0006
249 MEDICAL DEVICE IMPLANTATION 1 0.0006
250 VISUAL ACUITY REDUCED 21 0.0006
251 INHIBITORY DRUG INTERACTION 1 0.0006
252 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
253 ASCITES 18 0.0006
254 METASTASES TO LUNG 7 0.0006
255 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
256 FEMALE GENITAL TRACT FISTULA 1 0.0006
257 LAZINESS 1 0.0006
258 TREATMENT DELAYED 1 0.0006
259 PULMONARY TOXICITY 4 0.0006
260 METASTASIS 4 0.0006
261 INTESTINAL OBSTRUCTION 21 0.0006
262 RETINAL DETACHMENT 5 0.0005
263 METAMORPHOPSIA 1 0.0005
264 PNEUMOPERITONEUM 1 0.0005
265 CATHETER PLACEMENT 1 0.0005
266 STENOSIS 1 0.0005
267 CYSTOID MACULAR OEDEMA 1 0.0005
268 LIP DISORDER 1 0.0005
269 NEOPLASM 6 0.0005
270 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
271 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
272 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
273 METASTASES TO LIVER 9 0.0005
274 CATARACT OPERATION 3 0.0005
275 GENE MUTATION 1 0.0005
276 OBSTRUCTION 2 0.0005
277 CHANGE OF BOWEL HABIT 1 0.0005
278 SUBILEUS 1 0.0005
279 VASCULAR OCCLUSION 1 0.0005
280 SLEEP DEFICIT 1 0.0005
281 PULMONARY FIBROSIS 9 0.0005
282 ENTERITIS 3 0.0005
283 HAEMORRHAGE INTRACRANIAL 7 0.0005
284 THROMBOCYTOPENIA 52 0.0005
285 JAW FRACTURE 1 0.0005
286 HERPES SIMPLEX 3 0.0005
287 VISUAL IMPAIRMENT 55 0.0004
288 METASTASES TO MENINGES 1 0.0004
289 READING DISORDER 1 0.0004
290 ISCHAEMIA 2 0.0004
291 ABDOMINAL PAIN 101 0.0004
292 LYMPHOEDEMA 3 0.0004
293 LARGE INTESTINE PERFORATION 3 0.0004
294 HYPOMAGNESAEMIA 6 0.0004
295 PRURITUS GENITAL 1 0.0004
296 URINARY TRACT OBSTRUCTION 1 0.0004
297 POLYNEUROPATHY 5 0.0004
298 MYELODYSPLASTIC SYNDROME 6 0.0004
299 PANNICULITIS 1 0.0004
300 EYE OEDEMA 1 0.0004
301 HOSPICE CARE 4 0.0004
302 TRANSAMINASES INCREASED 9 0.0004
303 ILEUS 5 0.0004
304 NEUROTOXICITY 7 0.0004
305 COLITIS 15 0.0004
306 DIABETIC COMPLICATION 1 0.0004
307 CANCER PAIN 1 0.0004
308 MEAN CELL VOLUME INCREASED 1 0.0004
309 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
310 FAILURE TO THRIVE 2 0.0004
311 COMPARTMENT SYNDROME 1 0.0004
312 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
313 ANAL ABSCESS 2 0.0004
314 GINGIVITIS 2 0.0004
315 ABDOMINAL RIGIDITY 1 0.0004
316 GASTRIC PERFORATION 1 0.0004
317 SUBDURAL HAEMORRHAGE 1 0.0004
318 GASTROINTESTINAL PAIN 4 0.0004
319 NECROSIS 2 0.0004
320 LUNG CONSOLIDATION 1 0.0004
321 OCULAR DISCOMFORT 4 0.0004
322 DRUG TOLERANCE DECREASED 1 0.0004
323 PHARYNGEAL DISORDER 1 0.0003
324 PRODUCT LABEL CONFUSION 2 0.0003
325 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
326 STRIDOR 1 0.0003
327 INFUSION SITE REACTION 1 0.0003
328 URINE ANALYSIS ABNORMAL 1 0.0003
329 ATYPICAL PNEUMONIA 1 0.0003
330 PLATELET COUNT ABNORMAL 2 0.0003
331 VARICES OESOPHAGEAL 1 0.0003
332 DYSCHEZIA 1 0.0003
333 BLOOD CREATININE DECREASED 1 0.0003
334 INFUSION SITE SWELLING 2 0.0003
335 NON-CARDIAC CHEST PAIN 1 0.0003
336 INTRAOCULAR PRESSURE INCREASED 4 0.0003
337 ACUTE RESPIRATORY FAILURE 6 0.0003
338 GLAUCOMA 6 0.0003
339 DRUG RESISTANCE 8 0.0003
340 VITREOUS FLOATERS 3 0.0003
341 THERAPY CHANGE 3 0.0003
342 EYE PAIN 17 0.0003
343 PRODUCT STORAGE ERROR 26 0.0003
344 BRONCHIECTASIS 2 0.0003
345 UVEITIS 4 0.0003
346 HEPATIC CYST 1 0.0003
347 GINGIVAL BLEEDING 4 0.0003
348 WOUND COMPLICATION 1 0.0003
349 HEPATIC FIBROSIS 1 0.0003
350 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
351 NEOPLASM PROGRESSION 10 0.0003
352 FORMICATION 2 0.0003
353 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
354 JAUNDICE CHOLESTATIC 1 0.0003
355 GLOSSITIS 1 0.0003
356 RETINAL HAEMORRHAGE 2 0.0003
357 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
358 LIVER FUNCTION TEST INCREASED 6 0.0003
359 EYE IRRITATION 16 0.0003
360 MONOCYTE COUNT INCREASED 1 0.0003
361 RECTAL DISCHARGE 1 0.0003
362 MUCOSAL INFLAMMATION 7 0.0003
363 CATHETER SITE INFECTION 1 0.0003
364 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
365 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
366 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
367 HYPOALBUMINAEMIA 2 0.0003
368 CARDIOPULMONARY FAILURE 1 0.0003
369 EPIGASTRIC DISCOMFORT 1 0.0003
370 BRAIN FOG 4 0.0003
371 LYMPHADENOPATHY 9 0.0003
372 OESOPHAGEAL PAIN 1 0.0003
373 AZOTAEMIA 1 0.0003
374 SKIN PAPILLOMA 1 0.0002
375 VITAMIN B12 DEFICIENCY 1 0.0002
376 FEEDING DISORDER 5 0.0002
377 NEUTROPHIL COUNT DECREASED 10 0.0002
378 ABNORMAL FAECES 2 0.0002
379 INJECTION SITE EXTRAVASATION 3 0.0002
380 AORTIC DISSECTION 1 0.0002
381 GASTROINTESTINAL PERFORATION 1 0.0002
382 SENSATION OF FOREIGN BODY 2 0.0002
383 INFUSION SITE ERYTHEMA 2 0.0002
384 HYPERPYREXIA 1 0.0002
385 MUSCLE FATIGUE 1 0.0002
386 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
387 HEPATIC PAIN 1 0.0002
388 ABNORMAL SENSATION IN EYE 1 0.0002
389 TENSION HEADACHE 1 0.0002
390 BLOOD MAGNESIUM DECREASED 2 0.0002
391 HORDEOLUM 1 0.0002
392 HYSTERECTOMY 2 0.0002
393 IMMOBILE 1 0.0002
394 ONYCHOMYCOSIS 1 0.0002
395 ORAL CANDIDIASIS 3 0.0002
396 PARONYCHIA 1 0.0002
397 PLATELET COUNT DECREASED 24 0.0002
398 WHEELCHAIR USER 1 0.0002
399 PAPILLOEDEMA 1 0.0002
400 SUSPECTED OFF LABEL USE 1 0.0002
401 TACHYPNOEA 3 0.0002
402 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
403 DISEASE COMPLICATION 1 0.0002
404 PRODUCT DISTRIBUTION ISSUE 2 0.0002
405 PLEURAL EFFUSION 13 0.0002
406 HYPOCALCAEMIA 4 0.0002
407 HAEMATOTOXICITY 2 0.0002
408 CARDIAC TAMPONADE 1 0.0002
409 PULSE ABSENT 1 0.0002
410 IMPAIRED QUALITY OF LIFE 3 0.0002
411 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
412 ATELECTASIS 2 0.0002
413 ORGANISING PNEUMONIA 1 0.0002
414 BLOOD PRESSURE ABNORMAL 4 0.0002
415 ERYSIPELAS 1 0.0002
416 HYPOXIA 7 0.0002
417 EYELID PTOSIS 2 0.0002
418 FEMORAL NECK FRACTURE 1 0.0002
419 CACHEXIA 1 0.0002
420 SKIN NECROSIS 1 0.0002
421 DIPLOPIA 5 0.0002
422 GASTROINTESTINAL DISORDER 17 0.0002
423 NYSTAGMUS 1 0.0002
424 INJECTION SITE DISCHARGE 1 0.0002
425 CHEILITIS 1 0.0002
426 LUNG DISORDER 9 0.0002
427 NONSPECIFIC REACTION 1 0.0002
428 ASTHENOPIA 1 0.0002
429 PHOTOSENSITIVITY REACTION 3 0.0002
430 DEAFNESS UNILATERAL 1 0.0002
431 HYPERKERATOSIS 1 0.0002
432 NERVE INJURY 2 0.0002
433 INTRACRANIAL PRESSURE INCREASED 1 0.0002
434 PANCYTOPENIA 10 0.0002
435 MACULAR OEDEMA 1 0.0002
436 IMPAIRED DRIVING ABILITY 2 0.0002
437 SHOCK 4 0.0002
438 HYPOKALAEMIA 8 0.0002
439 ELECTROLYTE IMBALANCE 2 0.0002
440 PROTHROMBIN TIME PROLONGED 1 0.0002
441 LACRIMATION INCREASED 5 0.0002
442 HEPATIC CIRRHOSIS 3 0.0002
443 DIARRHOEA 103 0.0002
444 POISONING 2 0.0002
445 BRAIN OEDEMA 2 0.0002
446 PHOTOPSIA 1 0.0002
447 BLOOD URINE PRESENT 3 0.0002
448 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
449 INFUSION SITE PAIN 2 0.0002
450 HERNIA 3 0.0002
451 DEATH 131 0.0002
452 FEBRILE NEUTROPENIA 10 0.0002
453 SKIN MASS 1 0.0001
454 PRODUCT ADMINISTRATION ERROR 3 0.0001
455 METASTASES TO LYMPH NODES 1 0.0001
456 EYE MOVEMENT DISORDER 1 0.0001
457 PERIPHERAL COLDNESS 2 0.0001
458 PERITONITIS 3 0.0001
459 MENTAL STATUS CHANGES 4 0.0001
460 ABDOMINAL DISCOMFORT 24 0.0001
461 DEFAECATION URGENCY 1 0.0001
462 ABDOMINAL PAIN UPPER 29 0.0001
463 BRONCHOSPASM 2 0.0001
464 MYELOSUPPRESSION 5 0.0001
465 VISUAL FIELD DEFECT 1 0.0001
466 FAECES SOFT 1 0.0001
467 MOUTH HAEMORRHAGE 1 0.0001
468 SENSITIVE SKIN 1 0.0001
469 CEREBRAL DISORDER 1 0.0001
470 HYDRONEPHROSIS 1 0.0001
471 TROPONIN INCREASED 1 0.0001
472 HAEMODYNAMIC INSTABILITY 1 0.0001
473 HAEMOLYSIS 1 0.0001
474 MUSCULOSKELETAL CHEST PAIN 2 0.0001
475 TENDONITIS 2 0.0001
476 NERVOUS SYSTEM DISORDER 4 0.0001
477 CYANOSIS 2 0.0001
478 PNEUMOTHORAX 2 0.0001
479 BLOOD ALBUMIN DECREASED 1 0.0001
480 RENAL CYST 1 0.0001
481 ANAEMIA 24 0.0001
482 ULCER 2 0.0001
483 MIOSIS 1 0.0001
484 OXYGEN SATURATION DECREASED 7 0.0001
485 MUSCLE DISORDER 1 0.0001
486 MUSCLE TIGHTNESS 2 0.0001
487 NEURALGIA 3 0.0001
488 VOMITING 58 0.0001
489 NAUSEA 97 0.0001
490 EOSINOPHIL COUNT INCREASED 1 0.0001
491 GAIT INABILITY 4 0.0001
492 BONE PAIN 7 0.0001
493 HEPATITIS 3 0.0001
494 PRODUCT CONTAINER ISSUE 1 0.0001
495 ANAPHYLACTIC SHOCK 3 0.0001
496 MUSCULOSKELETAL DISCOMFORT 2 0.0001
497 PYELONEPHRITIS 1 0.0001
498 EOSINOPHILIA 2 0.0001
499 TUMOUR LYSIS SYNDROME 1 0.0001
500 GRIP STRENGTH DECREASED 1 0.0001
501 LUNG INFILTRATION 1 0.0001
502 LYMPHOCYTE COUNT DECREASED 2 0.0001
503 HEAD DISCOMFORT 2 0.0001
504 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
505 FACIAL PAIN 1 0.0001
506 ADVERSE DRUG REACTION 10 0.0001
507 CONSTIPATION 24 0.0001
508 ADVERSE EVENT 10 0.0001
509 UROSEPSIS 1 0.0001
510 NERVE COMPRESSION 1 0.0001
511 CONJUNCTIVITIS 2 0.0001
512 EYE SWELLING 4 0.0001
513 NEPHROPATHY 1 0.0001
514 DYSARTHRIA 4 0.0001
515 SQUAMOUS CELL CARCINOMA 1 0.0001
516 BLOOD SODIUM DECREASED 2 0.0001
517 ABDOMINAL DISTENSION 11 0.0001
518 GASTRIC ULCER 2 0.0001
519 FEELING JITTERY 2 0.0001
520 NEOPLASM MALIGNANT 7 0.0001
521 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
522 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
523 CHOLESTASIS 2 0.0001
524 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
525 NEUTROPENIA 14 0.0001
526 EAR PAIN 2 0.0001
527 PARAESTHESIA 16 0.0001
528 BODY TEMPERATURE DECREASED 1 0.0001
529 URINARY INCONTINENCE 3 0.0001
530 HYPOAESTHESIA 15 0.0001
531 BRAIN INJURY 1 0.0001
532 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
533 HEPATIC FAILURE 3 0.0001
534 TASTE DISORDER 2 0.0001
535 FLUSHING 10 0.0001
536 SUBARACHNOID HAEMORRHAGE 1 0.0001
537 MOTOR DYSFUNCTION 1 0.0001
538 BLOOD PRESSURE INCREASED 15 0.0001
539 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
540 CHEST DISCOMFORT 10 0.0001
541 HYPERBILIRUBINAEMIA 1 0.0001
542 TENDERNESS 1 0.0001
543 WEIGHT FLUCTUATION 1 0.0001
544 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
545 FULL BLOOD COUNT ABNORMAL 1 0.0001
546 SUDDEN DEATH 1 0.0001
547 HIP FRACTURE 3 0.0001
548 SKIN LACERATION 1 0.0001
549 SEPTIC SHOCK 4 0.0001
550 PULMONARY THROMBOSIS 1 0.0001
551 ASPIRATION 1 0.0001
552 ANAPHYLACTIC REACTION 5 0.0001
553 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
554 VIRAL INFECTION 3 0.0001
555 RASH MACULO-PAPULAR 2 0.0001
556 HEPATOTOXICITY 2 0.0001
557 PYREXIA 31 0.0001
558 PULMONARY OEDEMA 4 0.0001
559 SKIN INFECTION 1 0.0001
560 BLOOD CALCIUM DECREASED 1 0.0001
561 HEPATIC ENZYME INCREASED 6 0.0001
562 MYOCARDIAL ISCHAEMIA 1 0.0001
563 DERMATITIS CONTACT 1 0.0001
564 MICTURITION URGENCY 1 0.0001
565 FATIGUE 68 0.0001
566 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
567 VASCULITIS 1 0.0001
568 COGNITIVE DISORDER 4 0.0001
569 DYSPHONIA 5 0.0001
570 BLOOD IRON DECREASED 1 0.0001
571 ACCIDENT 1 0.0001
572 C-REACTIVE PROTEIN INCREASED 3 0.0001
573 WEIGHT DECREASED 23 0.0001
574 LIVER INJURY 2 0.0001
575 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
576 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
577 GENERALISED OEDEMA 1 0.0001
578 SEPSIS 9 0.0001
579 CYST 1 0.0001
580 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
581 EPISTAXIS 6 0.0001
582 SECRETION DISCHARGE 1 0.0001
583 DYSPNOEA EXERTIONAL 3 0.0001
584 CELLULITIS 4 0.0001
585 HAEMATEMESIS 2 0.0001
586 ERYTHEMA 16 0.0001
587 BACK PAIN 18 0.0001
588 BLOOD CREATININE INCREASED 5 0.0001
589 DEAFNESS 2 0.0001
590 MYALGIA 13 0.0001
591 DYSMENORRHOEA 1 0.0001
592 ADVERSE REACTION 1 0.0001
593 EYE HAEMORRHAGE 1 0.0001
594 CARDIAC FAILURE 6 0.0001
595 ASTHENIA 28 0.0001
596 BLOOD BILIRUBIN INCREASED 2 0.0001
597 OEDEMA 4 0.0001
598 DECREASED APPETITE 17 0.0001
599 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
600 HUNGER 1 0.0001
601 APHONIA 1 0.0001
602 HOSPITALISATION 11 0.0001
603 DEVICE OCCLUSION 1 0.0001
604 PNEUMONIA 23 0.0001
605 SKIN REACTION 1 0.0001
606 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
607 HEPATOCELLULAR INJURY 1 0.0001
608 RED BLOOD CELL COUNT DECREASED 2 0.0001
609 PARALYSIS 1 0.0001
610 SUBDURAL HAEMATOMA 1 0.0001
611 BALANCE DISORDER 6 0.0001
612 ANOSMIA 1 0.0001
613 LIVER DISORDER 3 0.0001
614 THROAT IRRITATION 3 0.0001
615 APHASIA 2 0.0001
616 STOMATITIS 4 0.0001
617 SKIN DISCOLOURATION 3 0.0001
618 DEVICE RELATED INFECTION 1 0.0001
619 ANKLE FRACTURE 1 0.0001
620 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
621 RENAL DISORDER 3 0.0001
622 ACUTE MYELOID LEUKAEMIA 1 0.0001
623 THERAPY PARTIAL RESPONDER 1 0.0001
624 BASAL CELL CARCINOMA 1 0.0001
625 PRODUCT USE COMPLAINT 1 0.0001
626 OCULAR HYPERAEMIA 3 0.0001
627 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
628 SENSORY DISTURBANCE 1 0.0001
629 INFECTION 9 0.0001
630 THROMBOSIS 5 0.0001
631 STAPHYLOCOCCAL INFECTION 2 0.0001
632 BLOOD PRESSURE DECREASED 4 0.0001
633 CHILLS 7 0.0001
634 EYE PRURITUS 2 0.0001
635 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
636 HAEMATURIA 2 0.0001
637 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
638 INFLAMMATION 3 0.0001
639 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
640 ISCHAEMIC STROKE 1 0.0001
641 GASTROENTERITIS VIRAL 1 0.0001
642 LEUKOCYTOSIS 1 0.0001
643 RESTLESS LEGS SYNDROME 1 0.0001
644 HYPERGLYCAEMIA 2 0.0001
645 UNDERDOSE 4 0.0001
646 MUSCLE SPASMS 10 0.0001
647 DYSURIA 2 0.0001
648 HYPERSENSITIVITY 10 0.0001
649 AGRANULOCYTOSIS 1 0.0001
650 FLATULENCE 3 0.0001
651 URINARY TRACT INFECTION 9 0.0001
652 PULMONARY EMBOLISM 5 0.0001
653 PROTEINURIA 1 0.0001
654 MALAISE 23 0.0001
655 SEIZURE 6 0.0001
656 DYSPNOEA 29 0.0001
657 DYSPEPSIA 5 0.0001
658 FULL BLOOD COUNT DECREASED 1 0.0000
659 DISCOMFORT 3 0.0000
660 BODY TEMPERATURE INCREASED 1 0.0000
661 FEELING HOT 3 0.0000
662 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
663 RIB FRACTURE 1 0.0000
664 PULMONARY HYPERTENSION 1 0.0000
665 CARDIO-RESPIRATORY ARREST 2 0.0000
666 DERMATITIS 1 0.0000
667 RENAL IMPAIRMENT 4 0.0000
668 EATING DISORDER 1 0.0000
669 IMPAIRED WORK ABILITY 1 0.0000
670 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
671 FAECES DISCOLOURED 1 0.0000
672 FEELING ABNORMAL 11 0.0000
673 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
674 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
675 COVID-19 8 0.0000
676 TACHYCARDIA 4 0.0000
677 TOOTH DISORDER 1 0.0000
678 RASH PAPULAR 1 0.0000
679 THERAPY NON-RESPONDER 2 0.0000
680 PERICARDIAL EFFUSION 1 0.0000
681 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
682 CARDIAC DISORDER 4 0.0000
683 SLEEP DISORDER 3 0.0000
684 PRODUCT PRESCRIBING ERROR 1 0.0000
685 THERAPY INTERRUPTED 3 0.0000
686 GAIT DISTURBANCE 8 0.0000
687 DIABETIC KETOACIDOSIS 1 0.0000
688 LOCALISED INFECTION 1 0.0000
689 MENTAL IMPAIRMENT 1 0.0000
690 RESPIRATORY FAILURE 3 0.0000
691 ENCEPHALOPATHY 1 0.0000
692 AGEUSIA 1 0.0000
693 UNEVALUABLE EVENT 3 0.0000
694 ABDOMINAL PAIN LOWER 1 0.0000
695 PRODUCT COMPLAINT 1 0.0000
696 FLUID RETENTION 2 0.0000
697 COUGH 11 0.0000
698 THERAPY CESSATION 2 0.0000
699 HAEMOGLOBIN DECREASED 4 0.0000
700 ILLNESS 4 0.0000
701 UNRESPONSIVE TO STIMULI 1 0.0000
702 HAEMATOMA 1 0.0000
703 HYPERTENSION 8 0.0000
704 RENAL FAILURE 5 0.0000
705 PAIN 23 0.0000
706 PALLOR 1 0.0000
707 TREATMENT FAILURE 3 0.0000
708 DIVERTICULITIS 1 0.0000
709 FEELING COLD 1 0.0000
710 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
711 NECK PAIN 2 0.0000
712 WOUND 1 0.0000
713 BLISTER 2 0.0000
714 SKIN EXFOLIATION 3 0.0000
715 PAIN IN JAW 1 0.0000
716 MUSCULAR WEAKNESS 4 0.0000
717 LETHARGY 2 0.0000
718 NEEDLE ISSUE 1 0.0000
719 DYSSTASIA 1 0.0000
720 PRODUCT DOSE OMISSION ISSUE 10 0.0000
721 LABORATORY TEST ABNORMAL 1 0.0000
722 RESPIRATORY DISORDER 1 0.0000
723 BLOOD POTASSIUM DECREASED 1 0.0000
724 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
725 VERTIGO 2 0.0000
726 EPILEPSY 1 0.0000
727 EMOTIONAL DISORDER 1 0.0000
728 CHEST PAIN 6 0.0000
729 FEMUR FRACTURE 1 0.0000
730 DRUG-INDUCED LIVER INJURY 1 0.0000
731 DRUG INEFFECTIVE 42 0.0000
732 DYSPHAGIA 3 0.0000
733 HEAD INJURY 1 0.0000
734 MIGRAINE 3 0.0000
735 HYPOTHYROIDISM 1 0.0000
736 MOVEMENT DISORDER 1 0.0000
737 HYPERHIDROSIS 4 0.0000
738 OFF LABEL USE 27 0.0000
739 DEEP VEIN THROMBOSIS 2 0.0000
740 PAIN IN EXTREMITY 9 0.0000
741 IMPAIRED HEALING 1 0.0000
742 HEADACHE 19 0.0000
743 HEART RATE INCREASED 3 0.0000
744 DEHYDRATION 4 0.0000
745 SKIN DISORDER 1 0.0000
746 URINARY RETENTION 1 0.0000
747 URTICARIA 5 0.0000
748 SOMNOLENCE 6 0.0000
749 TOXICITY TO VARIOUS AGENTS 5 0.0000
750 PRODUCT QUALITY ISSUE 4 0.0000
751 NIGHTMARE 1 0.0000
752 ARTHRALGIA 12 0.0000
753 DELIRIUM 1 0.0000
754 PRURITUS 11 0.0000
755 BURNING SENSATION 2 0.0000
756 HYPERKALAEMIA 1 0.0000
757 CEREBRAL HAEMORRHAGE 1 0.0000
758 MOBILITY DECREASED 2 0.0000
759 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
760 PANIC ATTACK 1 0.0000
761 HEPATIC FUNCTION ABNORMAL 1 0.0000
762 ALOPECIA 5 0.0000
763 RASH 11 0.0000
764 DYSKINESIA 1 0.0000
765 ANXIETY 7 0.0000
766 INFLUENZA LIKE ILLNESS 2 0.0000
767 DIZZINESS 12 0.0000
768 FALL 8 0.0000
769 LOSS OF CONSCIOUSNESS 3 0.0000
770 RECTAL HAEMORRHAGE 1 0.0000
771 HYPOACUSIS 1 0.0000
772 VAGINAL HAEMORRHAGE 1 0.0000
773 DEVICE DISLOCATION 1 0.0000
774 INTENTIONAL PRODUCT MISUSE 2 0.0000
775 MUSCULOSKELETAL STIFFNESS 2 0.0000
776 INSOMNIA 6 0.0000
777 SKIN IRRITATION 1 0.0000
778 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
779 OROPHARYNGEAL PAIN 2 0.0000
780 SWELLING 2 0.0000
781 RASH ERYTHEMATOUS 1 0.0000
782 DRUG INTOLERANCE 2 0.0000
783 HYPOGLYCAEMIA 1 0.0000
784 ATRIAL FIBRILLATION 2 0.0000
785 LEUKOPENIA 1 0.0000
786 SYNCOPE 2 0.0000
787 HYPOTENSION 4 0.0000
788 PERIPHERAL SWELLING 3 0.0000
789 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
790 MUSCULOSKELETAL PAIN 1 0.0000
791 PANCREATITIS 1 0.0000
792 TREATMENT NONCOMPLIANCE 1 0.0000
793 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
794 TREMOR 3 0.0000
795 WEIGHT INCREASED 4 0.0000
796 HYPONATRAEMIA 1 0.0000
797 CEREBROVASCULAR ACCIDENT 3 0.0000
798 HERPES ZOSTER 1 0.0000
799 PALPITATIONS 2 0.0000
800 SURGERY 1 0.0000
801 THERAPEUTIC RESPONSE DECREASED 1 0.0000
802 SWELLING FACE 1 0.0000
803 DRY SKIN 2 0.0000
804 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
805 BRONCHITIS 1 0.0000
806 DYSGEUSIA 1 0.0000
807 HALLUCINATION 1 0.0000
808 ACUTE KIDNEY INJURY 2 0.0000
809 DRUG INTERACTION 2 0.0000
810 CONFUSIONAL STATE 2 0.0000
811 DRY MOUTH 1 0.0000
812 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
813 BLOOD GLUCOSE INCREASED 2 0.0000
814 CONTUSION 1 0.0000
815 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
816 HAEMORRHAGE 1 0.0000
817 ASTHMA 1 0.0000
818 INCORRECT DOSE ADMINISTERED 2 0.0000
819 JOINT SWELLING 1 0.0000
820 EMOTIONAL DISTRESS 1 0.0000
821 OEDEMA PERIPHERAL 1 0.0000
822 INJECTION SITE ERYTHEMA 1 0.0000
823 CONDITION AGGRAVATED 2 0.0000
824 NASOPHARYNGITIS 1 0.0000
825 PRODUCT USE ISSUE 1 0.0000
826 DEPRESSION 1 0.0000
827 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
828 INJECTION SITE PAIN 1 0.0000